Today main “consumers” of the newest pharmacological medicines – “mice – erudites” and “rats – intellectuals”. On them substances which, probably, can stimulate cerebration of the person also are approved, improve memory at patients with diseases, at victims of an insult and people with a delay of mental development. The potential market of such preparations is really huge. Only in the USA 4 million person suffers Alzheimer’s disease, at 12 million the frustration known under the name ” feebly marked deterioration of functions ” (quite often it precedes development Alzheimer’s disease) is marked, and at 76 million person is more senior than 50 years forgetfulness and more serious forms of a memory impairment is observed. Preparations Modafinil are annually sold in the USA for the sum more than $1 billion (that few any proofs of that this plant improves memory). The sales volume of this medicine in Germany exceeds a sales volume of all inhibitors of the acetylcholinesterase used for a suspension of process of a memory impairment at Alzheimer’s disease, switching Aricep, Exelon and Reminyl.
Despite of an incessant stream of the information on the future revolution in creation of the preparations figuratively named one magazine ” viagra for a brain “, hardly it is possible to expect in the near future their occurrence in the market. Company Cortex Pharmaceu-ticals has developed a new class of stimulators of memory under name Ampacine, presumably enlarging a level of a glutamate in a nervous tissue. Today their efficiency is checked at treatment Alzheimer’s disease, feebly marked deterioration of functions and a schizophrenia.
The number of similar researches steadily grows. In the beginning of 2004 medicines for improvement the memories created in companies Helicon Therapeutics and Memory Pharmaceuticals will start to be tested. New York firm Axonyx has closely engaged in check of preparation Phenserine – the potent inhibitor of an acetylcholinesterase intended for treatment Alzheimer’s disease.
The known biologist from Princeton university Joe Z. Tsien has offered companies Eurekal Pharmaceuticals from San Francisco, cooperating with scientists from Shanghai, to engage in development of preparations which would combine achievements of modern genetics with properties of the medicines used in treatment by grasses.
Though the majority of preparations of new generation will not soon meet with official approval of authorities, their possible{probable} use has already caused a strong public resonance. The chapter{head} of the Presidential Council on bioethics, philosopher – moralist Leon R. Kass counts, that ” in those areas of human life where people till now reached{achieved} successes extremely due to discipline and self-feedback, the achievements received with the help of tablets, genic engineering or technical grafts, give swindle or cheapness “.
On the other hand, consumption of ” stimulators of cerebration ” became an integral part of a human way of life since people have started to drink coffee. If new ” activators of a brain ” indeed can become ” cerebral viagra ” and to take a strong place in our daily life there is a natural question: how such can take place and as far as their use can become wide? We shall recollect a history of previous generations of ” psychomotor stimulators “, the authorities which have received in due time official approval: Donepesil and Modafinil which have been developed exclusively in the therapeutic purposes. Today these preparations many healthy people, hoping to increase accept mental serviceability. They piously trust in their miracle properties in spite of the fact that scientific proofs of it it is not found almost. As some experts hint, force of the “stimulating” action these medicines differ nothing from the products amounting our usual breakfast.
